EAACI Congress 2025

Back
13 - 16 June 2025 Glasgow, United Kingdom

SEP-631: A Novel Selective and Potent Oral MRGPRX2 Inhibitor for the Treatment of Chronic Spontaneous Urticaria

Saturday 14 Jun, 12:00 PM - 12:00 PM Glasgow, United Kingdom